Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease

被引：0
|
作者：
E Rodríguez-Gallego
M Guirro
M Riera-Borrull
A Hernández-Aguilera
R Mariné-Casadó
S Fernández-Arroyo
R Beltrán-Debón
F Sabench
M Hernández
D del Castillo
J A Menendez
J Camps
R Ras
L Arola
J Joven
机构：
[1] Unitat de Recerca Biomèdica,Department of Biochemistry and Biotechnology
[2] Hospital Universitari Sant Joan,undefined
[3] Institut d’Investigació Sanitària Pere Virgili,undefined
[4] Universitat Rovira i Virgili,undefined
[5] Servei de Cirurgia General i de l’Aparell Digestiu,undefined
[6] Hospital Universitari de Sant Joan de Reus,undefined
[7] Universitat Rovira i Virgili,undefined
[8] Catalan Institute of Oncology and Girona Biomedical Research Institute,undefined
[9] Center for Omics Sciences,undefined
[10] Universitat Rovira i Virgili. Centre Tecnològic de Nutrició i Salut,undefined
[11] Campus of International Excellence Southern Catalonia,undefined
[12] Tarragona,undefined
[13] Spain,undefined
来源：
International Journal of Obesity | 2015年 / 39卷
关键词：
biomarker; citric acid cycle; energy; oxoglutaric acid; mitochondria; steatosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：279 / 287
页数：8
相关论文
共 50 条
  • [1] Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease
    Rodriguez-Gallego, E.
    Guirro, M.
    Riera-Borrull, M.
    Hernandez-Aguilera, A.
    Marine-Casado, R.
    Fernandez-Arroyo, S.
    Beltran-Debon, R.
    Sabench, F.
    Hernandez, M.
    del Castillo, D.
    Menendez, J. A.
    Camps, J.
    Ras, R.
    Arola, L.
    Joven, J.
    INTERNATIONAL JOURNAL OF OBESITY, 2015, 39 (02) : 279 - 287
  • [2] Role of α-ketoglutarate and β-hydroxybutyrate in morbid obesity-associated non-alcoholic fatty liver disease: metabolomic approach
    Cabre, N.
    Luciano-Mateo, F.
    Hernandez-Aguilera, A.
    Fernandez-Arroyo, S.
    Garcia-Heredia, A.
    Baiges-Gaya, G.
    Camps, J.
    Joven, J.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S428 - S428
  • [3] METABOLOMICS REVEALS THAT ALTERATIONS IN CIRCULATING A-KETOGLUTARATE MAY BE RELEVANT IN THE ASSESSMENT OF MORBID OBESITY-ASSOCIATED NONALCOHOLIC FATTY LIVER DISEASE
    Rodriguez-Gallego, E.
    Fernandez-Arroyo, S.
    Riera-Borrull, M.
    Hernandez-Aguilera, A.
    Guirro, M.
    Marine-Casado, R.
    Luciano-Mateo, F.
    Garcia-Heredia, A.
    Marti-Lindez, A. A.
    Beltran-Debon, R.
    Joven, J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E65 - E65
  • [4] Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD)
    Kragh Petersen, Sine
    Bilkei-Gorzo, Orsolya
    Govaere, Olivier
    Hartlova, Anetta
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (05)
  • [5] Mitochondrial abnormalities in obesity-associated non-alcoholic fatty liver disease in pediatrics: An ultrastructural study
    Hicks, J
    Barrish, J
    Zhu, SH
    Nichols, R
    Shulman, R
    MODERN PATHOLOGY, 2002, 15 (01) : 348A - 349A
  • [6] Mitochondrial abnormalities in obesity-associated non-alcoholic, fatty liver disease in pediatrics: An ultrastructural study
    Hicks, J
    Barrish, J
    Zhu, SH
    Nichols, R
    Shulman, R
    LABORATORY INVESTIGATION, 2002, 82 (01) : 348A - 349A
  • [7] Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
    Borges-Canha, Marta
    Neves, Joao Sergio
    Mendonca, Fernando
    Silva, Maria Manuel
    Costa, Claudia
    Cabral, Pedro M.
    Guerreiro, Vanessa
    Lourenco, Rita
    Meira, Patricia
    Salazar, Daniela
    Ferreira, Maria Joao
    Pedro, Jorge
    Leite, Ana
    Von-Hafe, Madalena
    Vale, Catarina
    Viana, Sara
    Sande, Ana
    Belo, Sandra
    Lau, Eva
    Freitas, Paula
    Carvalho, Davide
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [8] Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease
    Gwag, Taesik
    Mooli, Raja Gopal Reddy
    Li, Dong
    Lee, Sangderk
    Lee, Eun Y.
    Wang, Shuxia
    JHEP REPORTS, 2021, 3 (01)
  • [9] Obesity and non-alcoholic fatty liver disease
    Pourshams, A
    Fazel, I
    Yarahmadi, S
    Sotoudeh, M
    Malekzadeh, R
    GUT, 2004, 53 : A83 - A83
  • [10] Obesity and non-alcoholic fatty liver disease
    Asatiani, Ketevan
    Giorgadze, Ellen
    Chachibaia, Vasil
    Mirianashvili, Ketevan
    Bochorishvili, Ketevan
    Surmava, Arkadi
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S128 - S128
12345